Christopher Paskowski
Otolaryngology · Norman, OKNPI 1346298585
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 95 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 28.2% of the total. 2025 is the largest year on record at $1,122, 3.3 times the $336 reported in 2019.
Across 95 payments — averaging $34.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$938
- Sanofi$629
- Medtronic$445
- Inspire Medical Systems, Inc.$241
- Integra Lifesciences Corporation$193
- Intersect ENT, Inc.$173
- plus $702 from 15 others
What the payments were for
- Food & beverage$3,321100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 28 | $938 |
| Sanofi | 21 | $629 |
| Medtronic(2 entities) | 4 | $445 |
| Inspire Medical Systems, Inc. | 5 | $241 |
| Integra Lifesciences Corporation | 2 | $193 |
| Intersect ENT, Inc. | 3 | $173 |
| GSK | 5 | $118 |
| Paratek Pharmaceuticals, Inc. | 1 | $116 |
| Optinose US, Inc. | 6 | $112 |
| Stryker | 3 | $79 |
| Hikma Pharmaceuticals USA | 3 | $47 |
| Sanofi-aventis U.S. LLC | 2 | $43 |
| Kaleo, Inc. | 3 | $42 |
| Fortovia Therapeutics, Inc. | 2 | $30 |
| AstraZeneca | 1 | $23 |
| Acclarent, Inc | 1 | $22 |
| Cook Medical LLC | 1 | $19 |
| Alk-abello, Inc | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
| Novartis | 1 | $12 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$346
- PROPEL$315
- Acclarent Aera$168
- Inspira Air$168
- RELIEVA SPINPLUS NAV$168
- TruDi Probe$168
- Inspire$167
- STEALTHSTATION S8 PLATFORM$159
- NUZYRA$116
- FUSION$107
How this compares
$3,321 in reported general payments places this provider in the 75th percentile of 109 otolaryngology providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 23 | $461 |
| Prednisone | 12 | $15 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Norman
- Jeffrey BuytenNorman$4K
- Jeremy MooreNorman$4K
- Kibwei McKinneyOklahoma City$315K
- Richard BakerOklahoma City$17K
- Edward El RassiOklahoma City$13K
- Benjamin CollinsOklahoma City$10K
- Keith ClarkOklahoma City$6K
- Emily WhiteEdmond$6K
- Erica RomanoEdmond$6K
- Rachad MhawejOklahoma City$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.